Sotuvning sof marjinal rentabelligi: Solid Biosciences Inc. (SLDB)

SLDB (Solid Biosciences Inc.) - kompaniyaning tovar belgisi

Solid Biosciences Inc. (SLDB) uchun genetik dori vositalarining xavfsizligi tashish jarayonida harorat nazoratiga qat'iy rioya qilish orqali ta'minlanadi. Sof foyda marjalari moliyaviy dinamikani tasdiqlaydi, bunda 0.00 parametrning joriy holatini belgilaydi. Xatarlar turli gen yetkazib berish platformalari va keng qamrovli loyihalar portfeli orqali minimallashtirilgan. Miopatiyalarni davolashdagi yuqori texnologik salohiyat sinovlar yakunlangach, kelajakdagi raqobatlashish qobiliyatiga asos yaratadi.

Solid Corp (SLDB) Sotuvning sof rentabelligi: 04.07.2022 - 19.11.2026 davri uchun

Solid Biosciences Inc. kompaniyasining tahliliy kesimlari

- aksiya kursi va ekspertlarning narx prognozi:
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning barcha koʻrsatkichlari tahlili:Solid Biosciences, SLDB
Solid Bio yetakchi tovari

Ushbu ko'rsatkich kapital barqarorligini stress-testdan o'tkazish va portfel tuzish jarayonida aktivlarni saralash uchun juda muhimdir. U umumiy daromadning sof foyda ulushini o'lchab, xarajatlarni boshqarish samaradorligini aks ettiradi, bu esa Solid Biosciences Inc. (SLDB) daromad marjasida gen tadqiqotlarining diversifikatsiyasi alohida terapevtik loyihalarning potentsial muvaffaqiyatsizliklari holatida moliyaviy risklarni qanday yumshatishini baholash imkonini beradi.

Solid Biosciences Inc. kimlar bilan raqobatlashadi

TEM: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Repligen Inc. - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi RNA|CRSP - Sof marja|GeneDx - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi RARE|Beam Tx - Sotuvning sof marjinal rentabelligi|SRPT - Sotuvning sof marjinal rentabelligi|TWST (Twist Bio) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi TXG|Sof foyda bo'yicha sotuv rentabelligi NTLA|Stoke Therapeutics Inc (STOK) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi BLFS|Sof marja WVE (Wave Life Sciences Corp)|Sof marja Maze Therapeutics MAZE|Sof foyda normasi SION|PRME - Sof marja|Kompaniya sotuv marjasi Taysha TSHA|QURE: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi MeiraGTx PLC|RGNX (REGENXBIO Inc) - Sotuvning sof marjinal rentabelligi|Sof marja ocugen.com OCGN|Sotuvning sof marjinal rentabelligi PACB|Benitec - Sotuvning sof rentabelligi|Sof marja Design Therapeutics DSGN|Sotuvning sof marjinal rentabelligi Rocket Pharmaceuticals RCKT|Sof foyda marjasi 4D Molecular Corp|LXEO: Sof marja|KRRO (Korro Bio, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Editas Medicine (EDIT) - Sotuvning sof marjinal rentabelligi|Sof marja Silence Therapeutics Inc.|Sotuvning sof rentabelligi PRQR (proqr.com)|Sof marja Codexis Bio (CDXS)|Sotuvning sof marjinal rentabelligi sangamo.com (SGMO)|Sof marja nautilus.bio NAUT|Kompaniya sotuv marjasi Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Sotuvning sof marjinal rentabelligi|GBIO - Sotuvning sof marjinal rentabelligi|BOLD: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi XCUR|Sof marja Imunon|Phio Pharmaceuticals - Sof foyda marjasi|Sof marja Mustang Bio, Inc. (MBIO)|Kompaniya sotuv marjasi TransCode Therapeutics, Inc.|Sof marja Bionano Genomics BNGO|Sof foyda normasi APDN|BLUE - Sof marja|Sof foyda marjasi IPA|Omega Therapeutics, Inc. (OMGA) - Sof marja|Singular Genomics Corp (OMIC) - Sotuvning sof marjinal rentabelligi|RGLS (Regulus Therapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|SYRS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX